Journal list Promote Sponsor
verified SJR 0,427 · Q2 • database Scopus / SJR & Web of Science indexed
Therapeutic delivery
United Kingdom · Taylor and Francis Ltd.
workspace_premium Q2 — Pharmaceutical Science lock Subscription

Therapeutic delivery

Therapeutic delivery is a journal indexed in SJR in Pharmaceutical Science with an H index of 69. It has an SJR impact factor of 0,427 and it has a best quartile of Q2. It has an SJR impact factor of 0,427.

ISSN: 2041-5990
Publisher: Taylor and Francis Ltd.
Category: Pharmaceutical Science
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,427 Q2
H-index 69
Acceptance rate pie_chart
30% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,427

H-index

69

Docs (year)

75

Docs 3y

165

Total refs

5706

Cites 3y

397

Citable 3y

149

Cites/Doc 2y

1.9

Ref/Doc

76.08

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Challenges and new strategies for therapeutic peptide delivery to the CNS

View more

Zanamivir oral delivery: possibilities revisited

View more

Decreased blood-brain barrier expression of P-glycoprotein in Alzheimer's disease: impact on pathogenesis and brain access of therapeutic agents

View more

Controlled-release vaginal ring drug-delivery systems: a key strategy for the development of effective HIV microbicides

View more

Conference Report: UK PharmSci 2010: The Science of Medicines

View more

Conference Report: The International Conference on the Freeze-Drying of Pharmaceuticals and Biologicals

View more

Conference Report: 17th Annual Meeting of the German Society for Gene Therapy

View more

Computational models for the in silico analysis of drug delivery from drug-eluting stents

View more

Clinicians' perspectives on the use of drug-eluting contact lenses for the treatment of glaucoma

View more

Chitosan-based films for the sustained release of peptides: a new era in buccal delivery?

View more

Chitosan coatings to control release and target tissues for therapeutic delivery

View more

Chimeric adeno-associated virus and bacteriophage: a potential targeted gene therapy vector for malignant glioma

View more
SHOW MORE ARTICLES

Challenges and opportunities in the delivery of cancer therapeutics

View more

A pharmaceutics perspective on drug delivery to the nail: recent advances and challenges

View more

Cells as delivery vehicles for cancer therapeutics

View more

Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literature

View more

Buprenorphine: revisiting the efficacy of transdermal delivery system

View more

Buccal drug delivery: what's new and what does the future hold?

View more

Biomimetic and bioinspired nanoparticles for targeted drug delivery

View more

Biomaterial-based local drug delivery to brain tumors

View more

Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days

View more

Binary and ternary complexes of norfloxacin to improve the solubility of the active pharmaceutical ingredient

View more

Battling with environments: drug delivery to target tissues with particles and functional biomaterials

View more

An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes

View more

FAQs